Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(20)
•••
pigsandsheep
X
View Profile
View Bullboard History
Comment by
pigsandsheep
on Jan 09, 2022 3:21pm
RE:RE:RE:HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:
THEY HAVE 4 TRAILS...WOW WOW ...BUT WHAT HAPPENED WITH THE $12M THEY BLEW ON THEIR LAST "TRIALS" JUST MOVING TO NASDAQ WILL NOT GET A HUGE VALUATION...THEIR PAST RECORD ON "TRIALS"
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jan 09, 2022 3:12pm
RE:RE:RE:HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:
Algernon is bragging that a company has a low float after a consolidation, That it has 4 trials for while it has no patents for and is not funded for. Management has a history of under market raises
...more
Debt-Free and Thriving: Mining Company Reports 35% Revenue Growth in Q3 2024
posted Nov 12, 2024 9:00am by
Mandalay Resources Corp.
-
|
"Revenue growth and free cash flow generation reflect our cost controls and prudent capital management while benefitting from high metal prices. As of the end of Q3 our cash balance was a healthy $54.7 million – more than doubling since December 2023 – and we have fully repaid the $20 million outstanding balance on our revolving credit facility, strengthening our liquidity and financial flexibility ...read more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Jan 09, 2022 12:33pm
RE:RE:HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:
The fact is it's a great plan moving forward. So what, the stock split. There's been zero dilution since and if it remains ultra low i9t changes nothing in relation to someone's overall
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jan 08, 2022 9:15pm
RE:HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:
Ouch, rough fact sheet! Thanks for posting so others understand why not to invest. Management takes a company from .58 down to .04 and then conduct a 100-1 consolidation.... Now they have 4 trials
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jan 07, 2022 4:53pm
HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:
Corporate-Fact-Sheet-Jan7-22-Int-f.pdf
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jan 05, 2022 4:47am
The winners and losers of 2021
Bellus Health PHOTO DAVID BOILY, PRESS ARCHIVES Bellus stock gained 166% in 2021. Laval biopharmaceutical capped off a good year by presenting positive clinical trial results for its product in
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jan 05, 2022 3:49am
There was a time Moreau (CEO) and Williams (former CSO)
...told shareholders on BioPub and elsewhere in the web world that the Repurposed Drugs Strategy had a better than 60% chance of success at Phase II of the clinical trial process. However, the fine
...more
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Jan 05, 2022 2:50am
Nasdaq & Dilution Is The Entire Ball Game Moving Forward >>>
Christopher Moreau said his fellow Canadians are the primary reason the Algernon story has remained Upside | Down. Therefore, there appears to be no way out for what came out of the CEO's mouth
...more
(1121)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jan 04, 2022 12:42pm
RE:TIME TO CHANGE THE ADDRESS @ ALGERNON PHARMACEUTICALS INC.
The Happy New Year message: VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a
...more
(334)
•••
Goldhog
X
View Profile
View Bullboard History
Comment by
Goldhog
on Jan 03, 2022 9:59am
RE:TIME TO CHANGE THE ADDRESS @ ALGERNON PHARMACEUTICALS INC.
To basement apartment if this trend stays the same
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Dec 31, 2021 8:14pm
TIME TO CHANGE THE ADDRESS @ ALGERNON PHARMACEUTICALS INC.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Dec 31, 2021 1:46pm
RE:O Ye Of Little Faith
Sad to see a bag holder of a .58 stock at .04 holding on so tight when dilution is just around the corner #Sad
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Dec 31, 2021 1:16pm
RE:O Ye Of Little Faith
Correction: Ifenprodil - Small Cell Lung Cancer & Pancreatic Cancer. Algernon Pharmaceuticals Announces Positive Feedback from Algernon Pharmaceuticals Launches Pancreatic Cancer
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Post by
C10H12N2
on Dec 31, 2021 12:52pm
O Ye Of Little Faith
Your analogy is shallow and ill informed. In your own example you speak of other drugs that are being used to treat COVID-19. That is correct - OTHER DRUGS TREATING COVID VERSUS
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Dec 31, 2021 10:21am
RE:AGN manufactures it's own clinical grade Ifenprodil & DMT
C10H12N2 aka Tryptophen give your head a shake and sack a tug. AGN is repurposing drugs so no interest from anyone because there is no money in it. Example: Invermectin reduces hospitaization for
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Star Diamond Corporation Announces Third Quarter 2024 Results
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.